Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kay M Tomashek

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|January 7, 2012
Management of severe dengueChristopher J Gregory, Kay M Tomashek
Transfusion|August 12, 2011
Dengue: a potential transfusion-transmitted diseaseKay M Tomashek, Harold S Margolis
Pediatrics|December 7, 2007
"Late-preterm" infants: a population at riskWilliam A Engle, Kay M Tomashek, Carol Wallman, et al.
Transfusion|February 7, 2012
Estimated prevalence of dengue viremia in Puerto Rican blood donations, 1995 through 2010Lyle R Petersen, Kay M Tomashek, Brad J Biggerstaff
Forensic Science International|September 7, 2005
Commentary on investigation of sudden unexpected deaths in infancyKay M Tomashek, Carrie Shapiro-Mendoza, Terry W Davis
The New England Journal of Medicine|July 11, 2020
Remdesivir for the Treatment of Covid-19 - Preliminary Report. ReplyJohn H Beigel, Kay M Tomashek, Lori E Dodd
The New England Journal of Medicine|November 6, 2020
Racial Disproportionality in Covid Clinical TrialsKay M Tomashek, Aneesh K Mehta, Noreen A Hynes, et al.
Maternal & Child Nutrition|August 3, 2006
Risk of stillbirth in relation to maternal haemoglobin concentration during pregnancyKay M Tomashek, Cande V Ananth, Mary E Cogswell
Transfusion|January 10, 2012
Prevalence of anti-dengue immunoglobulin G antibodies among American Red Cross blood donors in Puerto Rico, 2006Hamish Mohammed, Kay M Tomashek, Susan L Stramer, et al.
Vaccines|November 14, 2019
Disease Resurgence, Production Capability Issues and Safety Concerns in the Context of an Aging Population: Is There a Need for a New Yellow Fever Vaccine?Kay M Tomashek, Mark Challberg, Seema U Nayak, et al.
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|January 7, 2012
Management of severe dengueChristopher J Gregory, Kay M Tomashek
Transfusion|August 12, 2011
Dengue: a potential transfusion-transmitted diseaseKay M Tomashek, Harold S Margolis
Pediatrics|December 7, 2007
"Late-preterm" infants: a population at riskWilliam A Engle, Kay M Tomashek, Carol Wallman, et al.
Transfusion|February 7, 2012
Estimated prevalence of dengue viremia in Puerto Rican blood donations, 1995 through 2010Lyle R Petersen, Kay M Tomashek, Brad J Biggerstaff
Forensic Science International|September 7, 2005
Commentary on investigation of sudden unexpected deaths in infancyKay M Tomashek, Carrie Shapiro-Mendoza, Terry W Davis
The New England Journal of Medicine|July 11, 2020
Remdesivir for the Treatment of Covid-19 - Preliminary Report. ReplyJohn H Beigel, Kay M Tomashek, Lori E Dodd
The New England Journal of Medicine|November 6, 2020
Racial Disproportionality in Covid Clinical TrialsKay M Tomashek, Aneesh K Mehta, Noreen A Hynes, et al.
Maternal & Child Nutrition|August 3, 2006
Risk of stillbirth in relation to maternal haemoglobin concentration during pregnancyKay M Tomashek, Cande V Ananth, Mary E Cogswell
Transfusion|January 10, 2012
Prevalence of anti-dengue immunoglobulin G antibodies among American Red Cross blood donors in Puerto Rico, 2006Hamish Mohammed, Kay M Tomashek, Susan L Stramer, et al.
Vaccines|November 14, 2019
Disease Resurgence, Production Capability Issues and Safety Concerns in the Context of an Aging Population: Is There a Need for a New Yellow Fever Vaccine?Kay M Tomashek, Mark Challberg, Seema U Nayak, et al.
Pageof 10